Rapport Therapeutics, Inc. RAPP PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s PP&E (net)?
- Rapport Therapeutics, Inc. (RAPP) reported PP&E (net) of $2.52M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Rapport Therapeutics, Inc.'s PP&E (net) decreased by 26.0% year-over-year, from $3.4M to $2.52M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s PP&E (net)?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s PP&E (net) has grown at a 24.6% compound annual growth rate (CAGR), from $1.92M to $2.98M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.